AVANIR Pharmaceuticals Financial Market Data
| Last Close 26-Aug-2008 |
$0.89 |
Price/ Sales Ratio |
7.54 |
| 52-Week High |
$2.84 |
Price/ Book Ratio |
9.90 |
| 52-Week Low |
$0.85 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
2.7 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$69.6 |
Return on Assets |
(37.9%) |
| Shares Outstanding (mil.) |
78.2 |
Return on Equity |
(3,088.2%) |
| Dividend Rate |
-- |
Current Ratio |
5.83 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
1.71 |
| # of Institutional Holders |
35 |
% Owned by Institutions |
13.0% |
| Latest Short Interest Ratio |
0.00 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
(39.3%) |
157.0% |
4.2% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
